An End-to-End Pharmaceutical Development Pathway to Rapidly Bring Poorly Soluble New Chemical Entities to the Market

Alexandre Gil Ph.D. is EU Business Development Director at STA Pharmaceutical, a WuXi AppTec company (WuXi STA) responsible for leading the business development for Drug Substance and Drug Product in Europe.

Prior to joining WuXi STA in 2021, Alexandre was engaged from over 20 years in various research and management positions at Pierre Fabre, Ethypharm, Virbac and Sanofi. Alexandre earned his Ph.D. in Pharmaceutical Sciences from Paris XI University, France.